Clinical trials
Not yet recruiting ST Elevation Myocardial Infarction trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
55 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2024 | 7 |
| 2025 | 16 |
| 2026 | 32 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Not yet recruiting | 55 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Assiut University | 12 |
| Beijing Anzhen Hospital | 3 |
| China National Center for Cardiovascular Diseases | 2 |
| CorFlow Therapeutics AG | 2 |
| First Affiliated Hospital Xi'an Jiaotong University | 2 |
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 2 |
| Shanghai MicroPort Rhythm MedTech Co., Ltd. | 2 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Beijing Northland Biotech. Co., Ltd. | 1 |
| Cairo University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| ST Elevation Myocardial Infarction | 55 |
| Myocardial Infarction | 15 |
| Non-ST Elevated Myocardial Infarction | 10 |
| Acute Coronary Syndrome | 7 |
| Coronary Artery Disease | 4 |
| Cardiovascular Diseases | 3 |
| No-Reflow Phenomenon | 3 |
| Shock, Cardiogenic | 3 |
| Anterior Wall Myocardial Infarction | 2 |
| Chest Pain | 2 |
Trials
Showing 76 to 55 of 55. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.